12738709

Source:http://linkedlifedata.com/resource/pubmed/id/12738709

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0032893, umls-concept:C0087111, umls-concept:C0242275, umls-concept:C0872152, umls-concept:C1516636, umls-concept:C2349179
pubmed:issue	5
pubmed:dateCreated	2003-5-9
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/CA68485, http://linkedlifedata.com/resource/pubmed/grant/R01 CA80195
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9502500
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Epidermal Growth Factor
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	1078-0432
pubmed:author	pubmed-author:ArteagaCarlos LCL, pubmed-author:BaselgaJoseJ
pubmed:issnType	Print
pubmed:volume	9
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1579-89
pubmed:dateRevised	2009-11-19
pubmed:meshHeading	pubmed-meshheading:12738709-Antineoplastic Agents, pubmed-meshheading:12738709-Clinical Trials as Topic, pubmed-meshheading:12738709-Disease Management, pubmed-meshheading:12738709-Drug Delivery Systems, pubmed-meshheading:12738709-Humans, pubmed-meshheading:12738709-Neoplasms, pubmed-meshheading:12738709-Receptor, Epidermal Growth Factor, pubmed-meshheading:12738709-Research Design, pubmed-meshheading:12738709-Treatment Outcome
pubmed:year	2003
pubmed:articleTitle	Clinical trial design and end points for epidermal growth factor receptor-targeted therapies: implications for drug development and practice.
pubmed:affiliation	Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-6307, USA. carlos.arteaga@vanderbilt.edu
pubmed:publicationType	Journal Article, Research Support, U.S. Gov't, P.H.S., Review, Research Support, Non-U.S. Gov't